David McCormack - Publications

Affiliations: 
The University of Western Ontario (Canada) 
Area:
Pharmacology, Cell Biology

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Barker AL, Eddy RL, MacNeil JL, McCormack DG, Kirby M, Parraga G. CT Pulmonary Vessels and MRI Ventilation in Chronic Obstructive Pulmonary Disease: Relationship with worsening FEV in the TINCan cohort study. Academic Radiology. PMID 32303446 DOI: 10.1016/j.acra.2020.03.006  0.322
2019 Eddy RL, Westcott A, Kirby M, Mccormack D, Parraga G. CT pulmonary vessel volume in ex-smokers with normal FEV1 European Respiratory Journal. 54. DOI: 10.1183/13993003.Congress-2019.Pa4810  0.367
2017 Capaldi D, Sheikh K, Eddy R, Svenningsen S, McCormack D, Parraga G. Fourier-decomposition of free-breathing pulmonary proton MRI in asthma European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Pa800  0.35
2017 Eddy R, Sheikh K, Capaldi D, Svenningsen S, McCormack D, Parraga G. Ventilation heterogeneity reversibility: asthma, COPD or ACOS? European Respiratory Journal. DOI: 10.1183/1393003.Congress-2017.Oa4646  0.305
2014 Kirby M, Pike D, Coxson HO, McCormack DG, Parraga G. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. Radiology. 273: 887-96. PMID 24960283 DOI: 10.1148/radiol.14140161  0.313
2013 Ouriadov A, Farag A, Kirby M, McCormack DG, Parraga G, Santyr GE. Lung morphometry using hyperpolarized (129) Xe apparent diffusion coefficient anisotropy in chronic obstructive pulmonary disease. Magnetic Resonance in Medicine. 70: 1699-706. PMID 23359386 DOI: 10.1002/mrm.24595  0.302
2011 Kirby M, Heydarian M, Wheatley A, Etemad-Rezai R, McCormack D, Parraga G. MO-F-211-08: Development and Application of Novel Hyperpolarized 3He Magnetic Resonance Imaging Segmentation to Measure Acute Treatment Effects in Pulmonary Disease Medical Physics. 38: 3731-3731. DOI: 10.1118/1.3613039  0.326
2011 Owrangi A, Wang J, Wheatley A, McCormack D, Cunningham I, Parraga G. SU-F-BRA-08: Development of Novel 1H Magnetic Resonance Imaging Methods to Map Lung Structure and Function Medical Physics. 38: 3701-3701. DOI: 10.1118/1.3612875  0.385
2011 Heydarian M, Choy S, Wheatley A, Mccormack D, Coxson HO, Lam S, Parraga G. Automated segmentation of lung airway wall area measurements from bronchoscopic Optical Coherence Tomography imaging Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7965. DOI: 10.1117/12.878194  0.323
2009 Kirby M, Mathew L, Wheatley A, McCormack D, Parraga G. Sci-Thurs AM: YIS-06: Longitudinal Hyperpolarized 3He Magnetic Resonance Imaging of Chronic Obstructive Pulmonary Disease Medical Physics. 36: 4316-4316. DOI: 10.1118/1.3244166  0.335
2007 Evans A, McCormack D, Ouriadov A, Etemad-Rezai R, Santyr G, Parraga G. Anatomical distribution of 3He apparent diffusion coefficients in severe chronic obstructive pulmonary disease. Journal of Magnetic Resonance Imaging : Jmri. 26: 1537-47. PMID 17968961 DOI: 10.1002/Jmri.21205  0.359
2007 Parraga G, Ouriadov A, Evans A, McKay S, Lam WW, Fenster A, Etemad-Rezai R, McCormack D, Santyr G. Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Investigative Radiology. 42: 384-91. PMID 17507809 DOI: 10.1097/01.Rli.0000262571.81771.66  0.357
2007 Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, ... ... McCormack D, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Annals of Internal Medicine. 146: 545-55. PMID 17310045 DOI: 10.7326/0003-4819-146-8-200704170-00152  0.375
2006 Farley KS, Wang LF, Razavi HM, Law C, Rohan M, McCormack DG, Mehta S. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology. 290: L1164-72. PMID 16414981 DOI: 10.1152/AJPLUNG.00248.2005  0.346
2006 Shelton JL, Wang L, Cepinskas G, Sandig M, Inculet R, McCormack DG, Mehta S. Albumin leak across human pulmonary microvascular vs. umbilical vein endothelial cells under septic conditions. Microvascular Research. 71: 40-7. PMID 16376951 DOI: 10.1016/j.mvr.2005.11.003  0.302
2004 Razavi HM, Wang le F, Weicker S, Rohan M, Law C, McCormack DG, Mehta S. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. American Journal of Respiratory and Critical Care Medicine. 170: 227-33. PMID 15059787 DOI: 10.1164/rccm.200306-846OC  0.305
2004 Yaghi A, Bend JR, Webb CD, Zeldin DC, Weicker S, Mehta S, McCormack DG. Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia. American Journal of Physiology. Lung Cellular and Molecular Physiology. 286: L1260-7. PMID 14766666 DOI: 10.1152/ajplung.00273.2003  0.755
2003 Yaghi A, Bradbury JA, Zeldin DC, Mehta S, Bend JR, McCormack DG. Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia. American Journal of Physiology. Lung Cellular and Molecular Physiology. 285: L1099-105. PMID 12882760 DOI: 10.1152/ajplung.00039.2003  0.749
2002 Yaghi A, Mehta S, McCormack DG. Delayed rectifier potassium channels contribute to the depressed pulmonary artery contractility in pneumonia. Journal of Applied Physiology (Bethesda, Md. : 1985). 93: 957-65. PMID 12183491 DOI: 10.1152/japplphysiol.01146.2001  0.714
2002 Dennie CJ, Veinot JP, McCormack DG, Rubens FD. Intimal sarcoma of the pulmonary arteries seen as a mosaic pattern of lung attenuation on high-resolution CT. Ajr. American Journal of Roentgenology. 178: 1208-10. PMID 11959733 DOI: 10.2214/ajr.178.5.1781208  0.367
2001 Yaghi A, Webb CD, Scott JA, Mehta S, Bend JR, McCormack DG. Cytochrome P450 metabolites of arachidonic acid but not cyclooxygenase-2 metabolites contribute to the pulmonary vascular hyporeactivity in rats with acute Pseudomonas pneumonia. The Journal of Pharmacology and Experimental Therapeutics. 297: 479-88. PMID 11303033  0.776
2000 Webert KE, Vanderzwan J, Duggan M, Scott JA, McCormack DG, Lewis JF, Mehta S. Effects of inhaled nitric oxide in a rat model of Pseudomonas aeruginosa pneumonia. Critical Care Medicine. 28: 2397-405. PMID 10921570 DOI: 10.1097/00003246-200007000-00035  0.318
1999 Yaghi A, McCormack DG. Pulmonary artery contractility in pneumonia: role of cyclooxygenase products and nitric oxide. Journal of Cardiovascular Pharmacology. 34: 468-74. PMID 10471009 DOI: 10.1097/00005344-199909000-00023  0.766
1999 Scott JA, McCormack DG. Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis. Journal of Applied Physiology (Bethesda, Md. : 1985). 86: 1739-44. PMID 10233142 DOI: 10.1152/JAPPL.1999.86.5.1739  0.369
1999 Vanderzwan J, McCaig L, Mehta S, Joseph M, Whitsett J, McCormack DG, Lewis JF. Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia. The European Respiratory Journal. 12: 1388-96. PMID 9877497 DOI: 10.1183/09031936.98.12061388  0.509
1999 Scott JA, McCormack DG. Nonadrenergic noncholinergic vasodilation of guinea pig pulmonary arteries is mediated by nitric oxide Canadian Journal of Physiology and Pharmacology. 77: 89-95. DOI: 10.1139/Y98-136  0.395
1998 Tyml K, Yu J, McCormack DG. Capillary and arteriolar responses to local vasodilators are impaired in a rat model of sepsis. Journal of Applied Physiology (Bethesda, Md. : 1985). 84: 837-44. PMID 9480941 DOI: 10.1152/Jappl.1998.84.3.837  0.336
1997 Keenan SP, Kernerman PD, Cook DJ, Martin CM, McCormack D, Sibbald WJ. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Critical Care Medicine. 25: 1685-92. PMID 9377883 DOI: 10.1097/00003246-199710000-00018  0.304
1997 Yaghi A, Paterson NA, McCormack DG. Differential effect of nitric oxide synthase inhibitors on acetylcholine-induced relaxation of rat pulmonary and celiac artery rings. Canadian Journal of Physiology and Pharmacology. 75: 279-86. PMID 9196853 DOI: 10.1139/cjpp-75-4-279  0.736
1996 Scott JA, Craig I, McCormack DG. Nonadrenergic noncholinergic relaxation of human pulmonary arteries is partially mediated by nitric oxide. American Journal of Respiratory and Critical Care Medicine. 154: 629-32. PMID 8810597 DOI: 10.1164/ajrccm.154.3.8810597  0.422
1996 Fox GA, Paterson NA, McCormack DG. Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis. Journal of Cardiovascular Pharmacology. 28: 30-5. PMID 8797133 DOI: 10.1097/00005344-199607000-00006  0.335
1996 Fox GA, Paterson NA, McCormack DG. Calcitonin gene-related peptide does not mediate the abnormal vascular reactivity observed in a rat model of acute Pseudomonas pneumonia. Journal of Cardiovascular Pharmacology. 27: 901-7. PMID 8761859 DOI: 10.1097/00005344-199606000-00019  0.457
1995 Yaghi A, Paterson NA, McCormack DG. Vascular reactivity in sepsis: importance of controls and role of nitric oxide. American Journal of Respiratory and Critical Care Medicine. 151: 706-12. PMID 7881660 DOI: 10.1164/ajrccm.151.3.7881660  0.752
1994 Fox GA, Paterson NA, McCormack DG. Effect of inhibition of NO synthase on vascular reactivity in a rat model of hyperdynamic sepsis. The American Journal of Physiology. 267: H1377-82. PMID 7524365 DOI: 10.1152/ajpheart.1994.267.4.H1377  0.361
1993 Casson AG, McCormack D, Craig I, Inculet R, Levin L. A persistent pulmonary lesion following chemotherapy for metastatic choriocarcinoma Chest. 103: 269-270. PMID 8417895 DOI: 10.1378/Chest.103.1.269  0.339
1993 McCormack DG, Crawley DE, Evans TW. New perspectives in the pulmonary circulation and hypoxic pulmonary vasoconstriction. Pulmonary Pharmacology. 6: 97-108. PMID 8358184 DOI: 10.1006/pulp.1993.1013  0.393
1993 Martin CM, Yaghi A, Sibbald WJ, McCormack D, Paterson NA. Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. The American Review of Respiratory Disease. 148: 164-72. PMID 8317793 DOI: 10.1164/Ajrccm/148.1.164  0.756
1993 Yaghi A, Paterson NA, McCormack DG. Nitric oxide does not mediate the attenuated pulmonary vascular reactivity of chronic pneumonia. The American Journal of Physiology. 265: H943-8. PMID 8214131  0.776
1993 Myers ML, Li GH, Yaghi A, McCormack D. Human internal thoracic artery reactivity to dopaminergic agents. Circulation. 88: II110-4. PMID 7900930  0.696
1993 McCormack DG, Rees RG, Crawley D, Barnes PJ, Evans TW. Sensory neuropeptides and hypoxic pulmonary vasoconstriction in the rat. Thorax. 48: 554-7. PMID 7686691 DOI: 10.1136/thx.48.5.554  0.398
1992 Fox GA, McCormack DG. The pulmonary physician and critical care. 4. A new look at the pulmonary circulation in acute lung injury. Thorax. 47: 743-7. PMID 1440472 DOI: 10.1136/thx.47.9.743  0.306
1992 Crawley DE, McCormack DG, Evans TW. Bleomycin-induced acute lung injury in the rat does not influence pulmonary vascular responsiveness in vitro. Critical Care Medicine. 20: 641-4. PMID 1374004 DOI: 10.1097/00003246-199205000-00016  0.493
1992 McCormack DG, Crawley DE, Barnes PJ, Evans TW. Bleomycin-induced lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor. Clinical Science (London, England : 1979). 82: 259-64. PMID 1372199 DOI: 10.1042/cs0820259  0.356
1991 Liu SF, Cai YN, Evans TW, McCormack DG, Barer GR, Barnes PJ. Ligustrazine is a vasodilator of human pulmonary and bronchial arteries. European Journal of Pharmacology. 191: 345-50. PMID 2086247 DOI: 10.1016/0014-2999(90)94167-V  0.448
1991 Morgan JM, McCormack DG, Griffiths MJD, Morgan CJ, Barnes PJ, Evans TW. Adenosine as a vasodilator in primary pulmonary hypertension Circulation. 84: 1145-1149. PMID 1884445 DOI: 10.1161/01.CIR.84.3.1145  0.405
1990 McCormack DG, Barnes PJ, Evans TW. Purinoceptors in the pulmonary circulation of the rat and their role in hypoxic vasoconstriction. British Journal of Pharmacology. 98: 367-72. PMID 2819324 DOI: 10.1111/j.1476-5381.1989.tb12606.x  0.31
1990 McCormack DG, Salonen RO, Barnes PJ. Effect of sensory neuropeptides on canine bronchial and pulmonary vessels in vitro. Life Sciences. 45: 2405-12. PMID 2481796 DOI: 10.1016/0024-3205(89)90004-0  0.406
1990 McCormack DG, Barnes PJ, Evans TW. Effects of dopexamine hydrochloride on hypoxic pulmonary vasoconstriction in isolated rat lung. Critical Care Medicine. 18: 520-3. PMID 2328598 DOI: 10.1097/00003246-199005000-00012  0.337
1989 McCormack DG, Mak JC, Minette P, Barnes PJ. Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery. European Journal of Pharmacology. 158: 293-7. PMID 3253104 DOI: 10.1016/0014-2999(88)90083-0  0.328
1989 McCormack DG, Clarke B, Barnes PJ. Characterization of adenosine receptors in human pulmonary arteries. The American Journal of Physiology. 256: H41-6. PMID 2912196 DOI: 10.1152/ajpheart.1989.256.1.H41  0.344
1989 McCormack DG, Mak JC, Coupe MO, Barnes PJ. Calcitonin gene-related peptide vasodilation of human pulmonary vessels. Journal of Applied Physiology (Bethesda, Md. : 1985). 67: 1265-70. PMID 2551879 DOI: 10.1152/jappl.1989.67.3.1265  0.397
1987 McCormack D, Morgan WKC. Fansidar hypersensitivity pneumonitis British Journal of Diseases of the Chest. 81: 194-196. PMID 3651313 DOI: 10.1016/0007-0971(87)90140-9  0.316
Show low-probability matches.